Medical Journals

Axl/Phosphatidylinositol 3-kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells.

Authors:
  • Collett Georgina D M
  • Sage Andrew P
  • Kirton John Paul
  • Alexander M Yvonne
  • Gilmore Andrew P
  • Canfield Ann E

From: Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, UK.

Circulation research

  • Publish Date: Mar 2007
  • ISSN: 1524-4571
  • Volume: 100
  • Issue: 4
  • Pages: 502-9
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Collett Georgina D M, Sage Andrew P, Kirton John Paul, et al. Axl/Phosphatidylinositol 3-kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells.. Circ. Res. Mar 2007;100:502-9

Abstract

The calcification of blood vessels correlates with increased morbidity and mortality in patients with atherosclerosis, diabetes, and end-stage kidney disease. The receptor tyrosine kinase Axl is emerging as an important regulator of adult mammalian physiology and pathology. This study tests the hypothesis that Axl prevents the deposition of a calcified matrix by vascular smooth muscle cells (VSMCs) and that this occurs via the phosphatidylinositol 3-kinase (PI3K) signaling pathway. First, we demonstrate that Axl is expressed and phosphorylated in confluent VSMCs and that its expression is markedly downregulated as these cells calcify their matrix. Second, we demonstrate that overexpression of wild-type Axl, using recombinant adenoviruses, enhances Axl phosphorylation and downstream signaling via PI3K and Akt. Furthermore, overexpression of Axl significantly inhibits mineral deposition by VSMCs, as assessed by alizarin red staining and (45)Ca accumulation. Third, the addition of a PI3K inhibitor, wortmannin, negates the inhibition of mineralization by overexpression of wild-type Axl, suggesting that activation of downstream signaling via PI3K is crucial for its inhibitory activity. In contrast, Axl-mediated signaling is not enhanced by overexpression of kinase-dead Axl and mineralization is accelerated, although beta-glycerophosphate is still required for this effect. Finally, the caspase inhibitor zVAD.fmk attenuates the increased mineralization induced by kinase-dead Axl, suggesting that kinase-dead Axl stimulates mineralization by inhibiting the antiapoptotic effect of endogenous Axl. Together, these results demonstrate that signaling through Axl inhibits vascular calcification in vitro and suggest that therapeutics targeting this receptor may open up new avenues for the prevention of vascular calcification in vivo.

Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, Animals, Calcinosis, Calcium, Cattle, Cells, Cultured, Humans, Mice, Muscle, Smooth, Vascular, Oncogene Proteins, Receptor Protein-Tyrosine Kinases, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 17255529


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.